Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients.

Santoro JD, Gould J, Panahloo Z, Thompson E, Lefelar J, Palace J

Open source

DOI
10.1007/s40120-023-00474-9
Published
2023 Aug
Container
Neurology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40120-023-00474-9,
  title = {Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients.},
  author = {Santoro JD and Gould J and Panahloo Z and Thompson E and Lefelar J and Palace J},
  year = {2023},
  journal = {Neurology and therapy},
  doi = {10.1007/s40120-023-00474-9},
  url = {https://doi.org/10.1007/s40120-023-00474-9}
}

RIS

TY  - JOUR
TI  - Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients.
AU  - Santoro JD
AU  - Gould J
AU  - Panahloo Z
AU  - Thompson E
AU  - Lefelar J
AU  - Palace J
PY  - 2023
JO  - Neurology and therapy
DO  - 10.1007/s40120-023-00474-9
UR  - https://doi.org/10.1007/s40120-023-00474-9
ER  - 

APA

JD, S., J, G., Z, P., E, T., J, L., & J, P. (2023). Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients.. Neurology and therapy. https://doi.org/10.1007/s40120-023-00474-9

Source records